No Data
Nuotai Biology (688076.SH): Compound pike sulfate sodium granules obtain pharmaceutical registration certificate.
On October 14, Geelonghui reported that Autobio Diagnostics (688076.SH) recently received the "Pharmaceutical Registration Certificate" for the compound sodium picosulfate granules approved and issued by the National Medical Products Administration. Compound sodium picosulfate granules are a compound preparation composed of sodium picosulfate, magnesium oxide, and citric acid. They are used before radiographic examination, endoscopic examination, or surgery to clean the intestines and are not used as routine laxatives.
Jiangsu Sinopep-Allsino Biopharmaceutical (SHSE:688076) Seems To Use Debt Quite Sensibly
Sinopep-Allsino Biopharma's Q3 Profit to Soar Up to 181%; Shares Up 3%
The first third-quarter forecast of the star board: Peptide active pharmaceutical ingredients 'hot selling', Nuotai biology's net profit increase reaches up to 181%.
①Nuote Bio is the first to release the performance forecast for the third quarter of 2024, benefiting from the sales growth of peptide active pharmaceutical ingredients, with an expected net income attributable to shareholders of 0.1 billion yuan to 0.14 billion yuan, a year-on-year increase of 100.56% to 180.78%. ②Nuote Bio is expanding its peptide workshop to meet the hot demand for GLP-1, expecting to further increase peptide production capacity by 10 tons per year by the first half of 2025.
NOTEC Biotech: NOTEC Biotech: Voluntary Disclosure Notice for the Third Quarter of 2024 Results Forecast
Nootech: Voluntary Disclosure Notice for the Third Quarter of 2024 Earnings Forecast
Earnings Not Telling The Story For Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (SHSE:688076) After Shares Rise 26%No Data
No Data
